Search by Drug Name or NDC

    NDC 63304-0721-05 Diltiazem hydrochloride 300 mg/1 Details

    Diltiazem hydrochloride 300 mg/1

    Diltiazem hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is DILTIAZEM HYDROCHLORIDE.

    Product Information

    NDC 63304-0721
    Product ID 63304-721_e419f648-fd63-4a90-be3c-0de9e4a0a147
    Associated GPIs 34000010127050
    GCN Sequence Number 016572
    GCN Sequence Number Description diltiazem HCl CAP ER 24H 300 MG ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 02325
    HICL Sequence Number 000182
    HICL Sequence Number Description DILTIAZEM HCL
    Brand/Generic Generic
    Proprietary Name Diltiazem hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Diltiazem hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name DILTIAZEM HYDROCHLORIDE
    Labeler Name Sun Pharmaceutical Industries, Inc.
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203023
    Listing Certified Through 2024-12-31

    Package

    NDC 63304-0721-05 (63304072105)

    NDC Package Code 63304-721-05
    Billing NDC 63304072105
    Package 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63304-721-05)
    Marketing Start Date 2018-10-31
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.30073
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description DILTIAZEM 24H ER(CD) 300 MG CP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis